Arcadia Biosciences (RKDA) Change in Cash (2014 - 2025)

Arcadia Biosciences (RKDA) has 12 years of Change in Cash data on file, last reported at -$861000.0 in Q4 2025.

• Quarterly Change in Cash fell 381.37% year-over-year to -$861000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$4.0 million (down 75.0% YoY) and the FY2025 annual result came in at -$4.0 million, down 75.0% from the prior year.
• Change in Cash declined to -$861000.0 in Q4 2025, from -$256000.0 in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $16.8 million in Q1 2021 to a low of -$9.5 million in Q2 2023.
• A 5-year average of -$789200.0 and a median of -$1.7 million in 2024 frame the typical range for Change in Cash.
• Annual changes were most pronounced in 2021 — Change in Cash jumped 268.85% — and 2025, when it plunged 381.37%.
• Tracing RKDA's Change in Cash over 5 years: stood at -$6.8 million in 2021, then surged by 69.67% to -$2.1 million in 2022, then slumped by 97.25% to -$4.1 million in 2023, then surged by 107.48% to $306000.0 in 2024, then sank by 381.37% to -$861000.0 in 2025.
• The last three Change in Cash figures came in at -$861000.0 (Q4 2025), -$256000.0 (Q3 2025), and -$1.8 million (Q2 2025), per Business Quant data.